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Transmembrane AMPA receptor regulatory
proteins (TARPs) are auxiliary AMPA receptor
subunits that regulate both the trafficking and
gatingproperties of AMPA receptors, anddiffer-
ent TARP isoforms display distinct expression
patterns in brain. Here, we compared the effects
of four TARP isoforms on the kinetics of AMPA
receptor currents. Each isoform slowed the de-
activationofGluR1currents,but theslowingwas
greatest with g-4 and g-8. Isoform-specific dif-
ferences in desensitization were also observed
that correlated with effects on deactivation.
TARP isoforms also differentially modulated
responses to trains of glutamate applications
designed to mimic high-frequency presynaptic
firing. Importantly, whereas both stargazin and
g-4 rescued excitatory synaptic transmission
in cerebellar granule cells from stargazer mice,
the decay ofminiature EPSCswas 2-fold slower
in neurons expressing g-4. The results show
that heterogeneity in the composition of AMPA
receptor/TARP complexes contributes to syn-
apse-specific differences in EPSC decays and
frequency-dependent modulation of neuro-
transmission.
INTRODUCTION
In the mammalian brain, fast neuron-to-neuron transmis-
sion of electrical impulses is primarily mediated by the
synaptic release of glutamate and activation of postsyn-
aptic AMPA receptors. AMPA receptor excitatory post-
synaptic currents (EPSCs) display a wide range of magni-
tudes and time courses (Conti and Weinberg, 1999;
Erreger et al., 2004; Jonas and Spruston, 1994), in part
reflecting variability in the number, composition, and
properties of the postsynaptic receptor population. Four890 Neuron 55, 890–904, September 20, 2007 ª2007 Elseviergenes encode individual AMPA receptor subunits
(GluR1-4), which are alternatively spliced to yield ‘‘flip’’
or ‘‘flop’’ variants of each isoform, and individual neurons
express multiple GluR isoforms that form heterotetramers
with distinct channel kinetics (Dingledine et al., 1999).
Several proteins have been identified that regulate the
number and subcellular localization of AMPA receptors
at synapses (Bredt and Nicoll, 2003; Collingridge et al.,
2004; Kim and Sheng, 2004; Malinow and Malenka,
2002; Scannevin and Huganir, 2000). One such auxiliary
protein, stargazin (STG or g-2), is a member of the trans-
membrane AMPA receptor regulatory protein (TARP) fam-
ily (Nicoll et al., 2006; Osten and Stern-Bach, 2006; Palmer
et al., 2005; Ziff, 2007) that consists of multiple isoforms:
stargazin, g-3, g-4, and g-8 (Tomita et al., 2003). Recently,
another familymember, g-7, has been characterized (Kato
et al., 2007). In addition to affecting AMPA receptor traf-
ficking (Chen et al., 2000; Tomita et al., 2004), stargazin
was the first auxiliary subunit shown to modulate the bio-
physical properties of AMPA receptors (Priel et al., 2005;
Tomita et al., 2005; Turetsky et al., 2005; Yamazaki
et al., 2004), and heterologous expression of a domi-
nant-negative stargazin in hippocampal neurons speeds
the decay of AMPA receptor-mediated miniature synaptic
currents (Tomita et al., 2005). Furthermore, TARP coex-
pression increases the efficacy of the partial agonist kai-
nate, making the channel phenotype more similar in this
regard to native channels (Tomita et al., 2005; Turetsky
et al., 2005).
It has been shown that the different TARP isoforms ex-
hibit distinct expression patterns in brain (Fukaya et al.,
2005; Kato et al., 2007; Tomita et al., 2003). If TARP mod-
ulation of AMPA receptor kinetics varies for different iso-
forms, then neuron-specific differences in TARP expres-
sion might contribute to synapse-specific variation in
EPSC kinetics and the fidelity of synaptic transmission. It
is not known, however, whether all TARP isoforms alter
AMPA receptor kinetics or, if so, whether they have similar
or distinct effects. Whether modulation by different iso-
forms reflects a common mechanism has not been inves-
tigated, and previous work on stargazin has not led to
a consensus regarding the mechanism underlying itsInc.
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TARP Isoforms and AMPA Receptor GatingFigure 1. TARP Isoforms Differentially
Modulate Kainate Efficacy and Decay
Kinetics
Inward currents evoked by 100ms applications
(bars) of 200 mM kainate (KA) or 10 mM gluta-
mate (glu) in the same outside-out patches
from cells transfected with GluR1 alone (left)
or GluR1 and the indicated TARP isoform. All
four TARPs increase the relative size of the
kainate-evoked currents. The increases seen
with stargazin are similar to those obtained
with g-3, both of which are more than twice
the increases seen for g-4 and g-8. Note that
TARP coexpression also slows the decays of
the glutamate-evoked currents and the slowing
is greater with g-4 and g-8.modulation of AMPA receptor kinetics. We concluded that
stargazin largely affected activation gating, increasing
the rate constant for channel opening (Nicoll et al., 2006;
Tomita et al., 2005; Zhang et al., 2006), but others con-
cluded that the primary effect of stargazin was on receptor
desensitization (Kott et al., 2007; Priel et al., 2005; Turet-
sky et al., 2005).
Here, we compare the properties of AMPA receptors
coexpressed with each of the four major TARP isoforms.
The results indicate that each TARP promotes a slow gat-
ing mode and that individual TARP isoforms have similar
effects on both deactivation and desensitization. For all
four isoforms, the underlying mechanism appears to re-
flect changes in AMPA receptor activation gating; how-
ever, the size of the changes differs, with g-4 and g-8 pro-
ducing significantly greater slowing of glutamate-evoked
currents than stargazin or g-3. Stargazin and g-4 differen-
tially modulate the decay of miniature EPSCs in cerebellar
neurons, and different isoforms have distinct effects on
receptor responses to repeated stimulation. The results
indicate that differential coassembly of TARP and AMPA
receptor isoforms contributes to synapse-specific varia-
tion in synaptic signaling.
RESULTS
TARP-induced increases in kainate efficacy are a reliable
indicator of their coassembly with AMPA receptors (To-
mita et al., 2005; Turetsky et al., 2005). We therefore first
compared the effect of each TARP on the relative efficacy
of kainate and glutamate after cotransfecting them with
GluR1. Significant increases in kainate efficacy were
observed in all our recordings.
When GluR1 was expressed alone, currents evoked by
200 mM or 500 mM kainate were of similar amplitude and
were only about 1% of the peak currents evoked in the
same patches by 10 mM glutamate. All four TARPs in-
creased the relative efficacy of kainate (Figure 1). The po-
tentiation of maximal kainate-evoked currents seen with
stargazin or g-3 was significantly greater and about twice
that seen with g-4 or g-8 (Table 1), in agreement with
results reported previously in oocytes (Tomita et al., 2005).NeurTARP Modulation of Desensitization Decays
Reveals Two Subfamilies of TARP Isoforms
Each of the four TARP isoforms also slowed the decays
of the glutamate-activated currents (Figure 1). To charac-
terize this effect further, we fitted the decays of AMPA
receptor currents during sustained applications of a near-
saturating concentration of glutamate. GluR1 flip was ex-
pressed alone or with each isoform individually in tsA201
cells, and outside-out patches from transfected cells were
exposed to 10 mM glutamate for 100 ms (Figure 2). Ex-
pression of GluR1 resulted in currents that decayed with
time constants and steady-state/peak current ratios
similar to previously published values (Erreger et al.,
2004). As noted in earlier work (Robert et al., 2001; Zhang
et al., 2006), the decay of the currents was biexponential
and displayed a small slow component that had an initial
amplitude corresponding to about 2% of the total peak
inward current (Figure 2A and Table 1).
Coexpression of each of the four TARP isoforms with
GluR1 prolonged the desensitization decays of gluta-
mate-evoked currents. The fast component of decay (tf)
was slowed and the relative amplitude of the slow compo-
nent increased significantly (Figure 2 and Table 1). The
increased prominence of the slow decay component
was substantial with each isoform and made single-
exponential fits clearly inferior, as can be seen from com-
parison of the typical two- and one-exponential fits ob-
tained for g-3 and g-4 in Figures 2C and 2D. As an overall
index of TARP modulation of GluR1 desensitization de-
cays, we used the time constants and relative amplitudes
of the two exponential components obtained from the
biexponential fits to calculate weighted time constants
of desensitization. As shown in Figure 2F, all four TARP
isoforms significantly increased the weighted time con-
stants compared with the mean value for GluR1, but the
increases were significantly larger with g-4 and g-8 than
with stargazin and g-3.
Coexpression of each TARP with GluR1 also resulted in
larger relative steady-state currents (Figure 2 and Table 1),
as noted for stargazin and g-3 in previous reports (Priel
et al., 2005; Tomita et al., 2005; Turetsky et al., 2005). As
for TARP modulation of decay kinetics, the effects onon 55, 890–904, September 20, 2007 ª2007 Elsevier Inc. 891
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TARP Isoforms and AMPA Receptor GatingTable 1. Effects of TARP Isoforms on GluR1 Desensitization Decays and Kainate Efficacy
tf (ms) ts (ms) As (%) ss/peak (%) KA/glu ratio
GluR1 (6) 2.48 ± 0.15 18.4 ± 1.7 2.3 ± 0.7 0.3 ± 0.1 0.01 ± 0.003
GluR1 + STG (11) 2.89 ± 0.22 12.6 ± 1.2b 26.2 ± 3.3a 2.3 ± 0.4a 0.30 ± 0.02b
GluR1 + g-3 (7) 3.21 ± 0.24 13.5 ± 0.5b 22.4 ± 2.0a 2.1 ± 0.4a 0.29 ± 0.01b
GluR1 + g-4 (5) 4.20 ± 0.46a,d 20.4 ± 1.9 33.4 ± 7.1a 5.2 ± 1.5a 0.12 ± 0.03a
GluR1 + g-8 (9) 3.76 ± 0.26a 19.6 ± 1.8 30.6 ± 4.6a 4.7 ± 1.0a,c 0.18 ± 0.04a
Mean (±SEM) values for the time constants of the fast and slow components (tf, ts), the relative amplitude of the slow component
(As), and the steady-state current (as a percentage of the peak) from biexponential fits to the decays of currents evoked by 100 ms
applications of 10mMglutamate. Currents were recorded in patches from cells transfectedwith GluR1 alone or cells cotransfected
with GluR1 and one of the four TARP isoforms. For each group, the right-hand column gives the mean ratio of the maximal currents
evoked by rapid applications of 200 mM kainate and 10 mM glutamate. Applications of 500 mM kainate were also made in some
patches and gave currents that did not differ in size from those evoked by 200 mMkainate. Comparisons of the various groupmeans
weremadewith one-way ANOVA or two-tailed Student’s t test assuming unequal variance (see Experimental Procedures). p < 0.05
was taken as an indication of statistically significant differences. The number of patches for each group is given in parenthesis in the
lefthand column.
a Significantly different from GluR1.
b Significantly different from GluR1, GluR1 + g-4, and GluR1 + g-8.
c Significantly different from GluR1 + STG and GluR1 + g-3.
d Significantly different from GluR1 + STG.the steady-state plateau currents were larger with g-4 and
g-8 than with stargazin and g-3.
TARP Modulation of Deactivation
and Desensitization Is Similar
To test the effect of the different TARP isoforms on deac-
tivation, each TARP was coexpressed individually with
GluR1, and ensemble currents were evoked in excised
patches by short pulses (1 or 2 ms) of 10 mM glutamate
(Figure 3). As for desensitization, the deactivation decays
were biexponential. All four TARPs slowed deactivation
and increased the contribution of the slow component to
the overall decay kinetics (Figure 3 and Table 2). Compar-
isons of weighted time constants from the biexponential
fits to the deactivation decays indicated that all four
TARPs significantly slowed deactivation, and the mean
values obtained with g-8 were significantly greater than
those with stargazin and g-3.
To compare the effect of each TARP isoform on deacti-
vation and desensitization, the individual values for the
two sets of weighted time constants were expressed as
a percentage of the corresponding mean value obtained
for GluR1 channels. There is a strong correlation between
the two sets of time constants, suggesting that a common
mechanism underlies the slowing of both deactivation and
desensitization (Figure 3F).
The TARP modulation of deactivation that we observed
resulted in substantial increases in total charge transfer
during the decays of the current at the end of the brief glu-
tamate applications. To quantify the effect of the individual
TARPs, the peak currents were assigned values of 1.0,
and the decays were integrated to obtain values for total
charge transfer (in arbitrary units). The mean values given
in Table 2 show that the four TARPs increased the total
charge transfer to different extents, with stargazin and892 Neuron 55, 890–904, September 20, 2007 ª2007 Elsevierg-3 producing a 2-fold increase and coexpression of g-4
and g-8 resulting in a 4-fold enhancement.
TARPs Increase Peak Open Probability
A variety of results support the conclusion that AMPA re-
ceptor activation and entry into desensitization occur in
parallel from the same set of closed states (Partin et al.,
1996; Raman and Trussell, 1995; Robert et al., 2001;
Sun et al., 2002; Vyklicky et al., 1991). This generally
agreed upon feature is illustrated in the simple kinetic
mechanism in Figure 4A and has the consequence that al-
terations in the rate constants for channel opening and
closing, b and a, produce similar effects on the rates of
deactivation and desensitization. In contrast, direct ef-
fects on the rate constants that govern the transit of chan-
nels in and out of desensitized states (d and g in Figure 4A)
do not necessarily alter deactivation decays. These con-
siderations suggest that the effects of each TARP on de-
sensitization are secondary to effects on activation gating.
We previously reported that stargazin had no effect on
meanopen time (Tomita et al., 2005), suggesting, by exclu-
sion, that stargazin increased b (Figure 4A). Estimates of
peak open probability (peak Popen) can also discriminate
effects on b from possible effects on a. At near-
saturating concentrations of glutamate (where the latency
to first opening is brief), only increases in b would be ex-
pected to increase peak Popen. Thus, if the different TARP
isoforms slow the kinetics of glutamate currents by in-
creasing the rateconstant for channel opening, they should
increase peak Popen, and the size of this effect should be
greater for g-4 and g-8 than it is for stargazin and g-3.
To test these predictions, we examined the effect of cy-
clothiazide (CTZ), an AMPA receptor modulator that
greatly reduces the rate constant for entry into desensiti-
zation (Partin et al., 1993, 1996). Because activation andInc.
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TARP Isoforms and AMPA Receptor GatingFigure 2. TARP Modulation of GluR1 Desensitization Is Isoform Specific
Inward currents elicited by 100 ms applications of 10 mM glutamate in outside-out patches from tsA201 cells transfected with GluR1 alone (A) or
GluR1 and stargazin (B), g-3 (C), g-4 (D), or g-8 (E). The initial glutamate-evoked current decays quickly as the channels desensitize. The speed
and extent of desensitization were reduced by TARP coexpression, and single-exponential fits to the decays were obviously poor. The decays of
all the currents were fitted better with functions that consisted of two exponential components and a steady-state current (thin solid lines, individual
components shown as dotted lines). The time constants obtained from the biexponential fits to the currents shown and the relative amplitude of the
slower component of decay (in percent) are indicated. Dashed lines show the baseline current before and after the glutamate application. For g-3 and
g-4 (C and D), the left panels show the biexponential fits, and the right panels show the same currents fitted with single-exponential functions (plus
plateau current). The single-exponential fits gave decay time constants of 4.9 and 9.5 ms (C and D). The insets in (C) and (D) show the one- and
two-exponential fits (top and bottom traces) on an expanded time scale. (F) The time constants and relative amplitudes of the two components ob-
tained from the biexponential fits were used to calculate weighted time constants of desensitization. The bar graph shows the mean (+SD) values
obtained for GluR1 alone and for coexpression of GluR1 and each of the four TARP isoforms. All four isoforms significantly slowed GluR1 desensi-
tization (p < 0.05). The values for stargazin and g-3 were not significantly different, and both isoforms slowed desensitization significantly less than g-4
or g-8 (p < 0.05). The number of patches in each group is given in Table 1.desensitization occur largely in parallel and because for
homomeric GluR1 channels b is only about 4-fold larger
than d (Robert and Howe, 2003), a substantial proportion
of GluR1 channels desensitize without ever opening
when desensitization is intact. However, virtually all chan-
nels open in response to glutamate when d is reduced by
CTZ (peak Popenz1.0), and the ratio of the peak currents
in the absence and presence of CTZ therefore gives an
estimate of peak Popen (without CTZ).
Coexpression of each of the four TARP isoforms re-
duced CTZ-induced increases in peak glutamate-evoked
currents through GluR1 channels, and the increase in
peak Popen assessed in this way was greater with g-4
and g-8 than with stargazin and g-3 (Figures 4B and 4C).
This result is consistent with the conclusion that all four
TARPs increase peak Popen by increasing the b/d ratio. Be-
cause alterations in dwould not be expected to alter deac-
tivation decays for a low-affinity agonist like glutamate, inNeutotal the results are most consistent with the conclusion
that all four TARPs primarily alter activation gating, an ef-
fect that is larger for g-4 and g-8 than it is for stargazin and
g-3. The size of the increases in peak Popen (Figure 4C) are
consistent with the modest increases in b required to ac-
count for the slowing of deactivation and desensitization
decays observed for the four isoforms.
The First Extracellular Domain Determines
Isoform-Specific Effects on Decay Kinetics
Previous investigations of chimeric TARP constructs indi-
cated that the effects of stargazin on receptor gating were
primarily determined by sequence elements in Ex1, the
first extracellular domain (Tomita et al., 2005). The results
presented above show that coexpression of stargazin or
g-3 with AMPA receptor subunits resulted in larger in-
creases in kainate efficacy than coexpression of g-4 or
g-8, whereas the latter two TARPs producedmore slowingron 55, 890–904, September 20, 2007 ª2007 Elsevier Inc. 893
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TARP Isoforms and AMPA Receptor GatingFigure 3. Isoform-Specific Slowing of Deactivation
Inward currents elicited by 1ms applications (bars above current traces) of 10 mM glutamate to outside-out patches transfected with GluR1 alone (A)
or GluR1 and stargazin, g-3, g-4, or g-8 (B–E). Thin solid lines show the biexponential fits to the decays of the currents. Individual components are
shown as dotted lines. The time constants obtained from the fits are indicated, as is the relative amplitude of the slow component of decay (in percent).
(F) For each patch analyzed (Table 2), weighted time constants of deactivation were calculated from the biexponential fits to the deactivation decays
of the glutamate-evoked currents. The individual values were then expressed as a percentage of the mean value obtained for GluR1 alone. The mean
values for each group are plotted against the corresponding time constants obtained for desensitization. The bars indicated SEM, which in some
cases is less than half the symbol size. The linear fit to the data gave a slope of 0.66 and a correlation coefficient of 0.96.of deactivation and desensitization decays for currents
evoked by glutamate. The results suggest that the two
pairs of TARPs represent two subfamilies, a conclusion
supported by earlier phylogenetic analysis of sequence
homology among TARP isoforms and related proteins (To-
mita et al., 2003). Interestingly, sequence comparison of
the Ex1 domains of the four isoforms shows that stargazin894 Neuron 55, 890–904, September 20, 2007 ª2007 Elsevierand g-3 differ substantially from g-4 and g-8 in the first half
of Ex1 (Figure 5A).
To explore further the role of the Ex1 domain in TARP
modulation of AMPA receptor gating, we constructed chi-
meras in which the Ex1 domains were swapped between
stargazin and g-4 (Figure 5A) and coexpressed the chi-
meras with GluR1. Examples of the effect of each chimeraTable 2. Effect of TARP Isoforms on GluR1 Deactivation Decays
t1 (ms) t2 (ms) A2 (%) Charge Transfer
GluR1 (5) 0.99 ± 0.10 8.0 ± 1.1 2.4 ± 0.6 6.4 ± 0.8
GluR1 + STG (4) 1.64 ± 0.28 9.2 ± 0.5 9.6 ± 2.6a 12.4 ± 2.4
GluR1 + g-3 (6) 2.14 ± 0.27a 12.8 ± 2.6 7.7 ± 1.5 15.2 ± 1.1a
GluR1 + g-4 (5) 3.16 ± 0.50a,c 16.3 ± 4.5 10.4 ± 1.0a 23.8 ± 4.7a,c
GluR1 + g-8 (4) 3.28 ± 0.20b 23.8 ± 3.0b 9.1 ± 0.7a 26.7 ± 1.9b
Mean (±SEM) values for the time constants of the fast and slow components of deactivation (t1, t2), the relative amplitude of the
slow component (A2), and the total charge transfer (in arbitrary units). Individual values were obtained from fits to the decays of cur-
rents evoked by 1 or 2ms applications of 10mMglutamate in patches from cells transfectedwithGluR1 alone or cells cotransfected
with GluR1 and one of the four TARP isoforms. The number of patches from which results were obtained is given in parenthesis in
the lefthand column.
a Significantly different from GluR1.
b Significantly different from GluR1, GluR1 + STG, and GluR1 + g-3.
c Significantly different from GluR1 + STG.Inc.
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TARP Isoforms and AMPA Receptor GatingFigure 4. TARP Isoforms Differentially Modulate Peak Open Probability
(A) Simple kinetic model that illustrates the parallel nature of AMPA receptor activation and desensitization. As in more complete models that incor-
porate the dimer-of-dimers structure of the receptors (Robert and Howe, 2003), glutamate (G) binds to the receptors (R) and occupied channels (RG)
open (O) or desensitize (D) from the same closed states.
(B) Currents evoked by 100ms applications of 10mMglutamate in the absence and presence of CTZ (200 mM) to estimate the relative increase in peak
open probability that occurs after markedly reducing entry into desensitization. The currents were recorded in patches from cells transfected with
GluR1 alone (left), GluR1 and stargazin (middle), or GluR1 and g-8 (right). The records were scaled so that the peak currents in CTZ were the
same size. Arrowheads indicate the peak currents in the absence of CTZ.
(C) Bar graph showing the mean peak open probability (+SEM) of the glutamate-evoked currents without and with CTZ for GluR1 alone (-) and in
patches from cells coexpressing stargazin, g-3, g-4, or g-8. All four TARPs increased the peak open probability of the receptors (defined as the ratio
of the peak currents without and with CTZ). The enhancement of peak Popen is greatest for g-4 and g-8 (values significantly greater than GluR1 alone,
p < 0.01, one-way ANOVA). The value for g-3 was significantly different from GluR1 alone or GluR1 and g-4 or g-8, but not from GluR1 and STG, if
compared with two-tailed Student’s t tests (p < 0.05).on desensitization decays and kainate/glutamate ratios
are shown in Figure 5B. The bar graphs in Figures 5C
and 5D compare the mean values for kinetic parameters
obtained with the two chimeras with the data reported
above for coexpression of stargazin or g-4. Coexpression
of stargazin containing the g-4 Ex1 domain (STG-Ex1-g4)
produced greater slowing of desensitization decays than
stargazin, increasing both tf and ts significantly. Con-
versely, replacing the Ex1 domain in g-4 with that from
stargazin (g4-Ex1-STG) produced less slowing of desensi-
tization decays than g-4. The values of tf and ts were sig-
nificantly smaller than with g-4 and were similar to those
obtained with stargazin (Figure 5C). Coexpression of
both chimeras resulted in larger slow components and
plateau currents than coexpression of their corresponding
parent constructs; however, similar to the effect on the
time constants, swapping the Ex1 domains inverted the
rank order of the pairs (stargazin < g-4, whereas g4-Ex1-
STG <STG-Ex1-g4). Importantly, comparison of weighted
time constants calculated for the four groups showed
that g-4 and STG-Ex1-g4 slowed desensitization decays
significantly more than STG or g4-Ex1-STG, which were
not significantly different from each other (Figure 5D).
Estimates of peak Popen values from measurements of
the increase in peak glutamate-evoked currents produced
by CTZ also show that the effects on gating are related to
sequence elements in Ex1 (Figure 5E). In total, the results
indicate that the isoform-specific differences in TARP
modulation of GluR1 gating kinetics result largely, perhaps
exclusively, from isoform-specific differences in the Ex1
domains.
In contrast to the phenotype inversion seen for TARP
effects on desensitization decays, the kainate/glutamate
ratios obtained with both chimeras were larger than with
either stargazin or g-4 and were not significantly differentNeufrom each other (Figure 5B). Although these data demon-
strate that the Ex1 domain contributes to the effects of
TARP coexpression on kainate efficacy, clearly the Ex1
domain is not sufficient to explain these effects, and the
effects of TARP coassembly on kainate responses proba-
bly reflect interactions between multiple protein domains,
perhaps including transmembrane regions (Korber et al.,
2007a; Tomita et al., 2005).
TARP Modulation Varies for Different AMPA
Receptor Subunits
To test whether the effects of the TARP isoforms on the ki-
netic behavior of AMPA receptors varies for different GluR
subunits, we examined TARP modulation of GluR2 and
GluR4 channels. The results obtained for GluR4 channels
were similar to those obtained for GluR1. For GluR2-Q
channels, stargazin increased kainate efficacy, but coex-
pression of g-8 produced only small effects and did not
potentiate steady-state currents. In addition, stargazin,
g-4, and g-8 all produced similar slowing of desensitiza-
tion decays, in contrast to the isoform-specific results
for GluR1 andGluR4 (see the Supplemental Data available
with this article online for details).
Stargazin and g-8 Have Distinct Effects
on the Kinetics of Heteromeric Channels
The characteristics of most native channels are consistent
with the inclusion of GluR2 in heteromeric receptors (Gei-
ger et al., 1995;Washburn et al., 1997). We therefore com-
pared the effects of stargazin and g-8 on the desensitiza-
tion kinetics of GluR1-GluR2 heteromeric channels. The
edited (R) version of GluR2 was used for these experi-
ments, and 0.2 mM spermidine was included in the inter-
nal solution to evaluate differences in voltage-dependentron 55, 890–904, September 20, 2007 ª2007 Elsevier Inc. 895
Neuron
TARP Isoforms and AMPA Receptor GatingFigure 5. The Ex1 Domain Determines TARP Modulation of Decay Kinetics
(A) Sequence alignment across the first extracellular domain of the four TARP isoforms investigated (Ex1, top) and a schematic illustrating the struc-
ture of chimeras in which the Ex1 domain was swapped between stargazin and g-4. The four predicted transmembrane segments are numbered. In
the sequence alignment, asterisks indicate residues identical across all four isoforms. Hydrophobic and uncharged polar residues are highlighted in
green and pink, respectively. Residues primarily positively or negatively charged at physiological pH are highlighted in red and blue.
(B) Inward currents in response to 100 ms applications of 10 mM glutamate (left) and 200 mM kainate (right) in patches from cells cotransfected with
GluR1 and STG-Ex1-g4 (top) or GluR1 and g4-Ex1-STG (bottom). The glutamate-evoked currents were fitted with biexponential functions (solid lines).
Dotted lines show individual components, and dashed lines show the baseline current. The time constants and relative amplitude of the slow com-
ponent (in percent) are given on the insets, which display the same currents on an expanded scale.
(C) Bar graphs showing the mean (+SEM) values for the time constants of the fast and slow components (tf, ts), the relative amplitude of the slow
component of decay, and the steady-state current (as a percentage of the peak) that were obtained from fits to desensitization decays. The data
for stargazin and g-4 from Table 1 are compared with the results obtained for coexpression of GluR1 with the STG-Ex1-g4 and g4-Ex1-STG
chimeras (left to right for each data set).
(D and E) Mean (+SEM) values of the weighted time constant of desensitization and the peak Popen values for stargazin and g-4 (Table 1) and the STG-
Ex1-g4 and g4-Ex1-STG chimeras. The bar legend in panel (C) also applies to (D) and (E).block by internal polyamines (Bowie and Mayer, 1995;
Donevan and Rogawski, 1995).
Figure 6 shows mean current-voltage relationships
obtained for peak glutamate-evoked currents in experi-
ments where GluR1 or GluR1 and GluR2-R were ex-896 Neuron 55, 890–904, September 20, 2007 ª2007 Elsevier Ipressed without and with stargazin or g-8. The inwardly
rectifying phenotype seen in the GluR1 and GluR2 coex-
pression experiments, as well as the small size of the
currents (Swanson et al., 1997), confirms that most chan-
nels were GluR1-GluR2 heteromers (Figures 6A and 6B).nc.
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TARP Isoforms and AMPA Receptor GatingFigure 6. TARP Modulation of Hetero-
meric GluR1-GluR2 Channels
(A) Current-voltage relationships for GluR1 and
GluR1-GluR2 channels without and with coex-
pression of stargazin or g-8. The edited version
of GluR2 was used, resulting in a marked de-
crease in inward rectification. Peak currents
were measured during voltage jumps from
80 mV to +80 mV and normalized to the
size of the currents at 80 mV.
(B) Examples of individual currents obtained
at 40 mV and +40 mV in the GluR1-stargazin
coexpression experiments with and without
GluR2-R.
(C) Currents through GluR1-GluR2 channels
evoked by 10 mM glutamate without (left) and
with coexpression of stargazin (middle) or g-8
(right). The glutamate-evoked currents were
fitted with biexponential functions (solid lines).
Dotted lines show individual components,
and the dashed lines show the baseline
current.
(D) Bar graphs showing the mean (+SEM)
values for the time constant and relative ampli-
tude of the slow components (ts, As), the
weighted time constant from the biexponential
fits, and ratios of the maximum currents
evoked by 200 mM kainate and 10 mM gluta-
mate. The results of statistical comparisons
are given in the text.As reported previously for stargazin (Turetsky et al., 2005),
coexpression of either TARP isoform reduced the inward
rectification of the channels at positive membrane poten-
tials.
Stargazin and g-8 had distinct effects on GluR1-GluR2
heteromeric channels (Figures 6C and 6D). The time con-
stants of the fast or slow decay components obtainedwith
stargazin were similar to control values, whereas coex-
pression of g-8 significantly increased both tf and ts rela-
tive to the values obtained for GluR1-GluR2 alone or with
stargazin (p < 0.01, one-way ANOVA). Stargazin markedly
increased the amplitude of the slow component of decay
and the steady-state current. In contrast, the slow compo-
nent was significantly smaller with g-8, although still larger
than control values (p < 0.05, one-way ANOVA). The
weighted time constants calculated for each of the three
data sets were all different from each other, and g-8 pro-
duced greater overall slowing than stargazin. Unlike the
results with GluR2 alone, coexpression of g-8 enhanced
both kainate efficacy (Figure 6D) and steady-state cur-
rents for GluR1-GluR2 channels. Therefore, while there
are significant GluR-dependent differences in the effect
of individual TARP isoforms, the major isoform-specific
differences seen here for GluR1 and GluR4 homomers
are also evident for heteromeric channels containingNeuroGluR2, suggesting these differences are relevant to the
kinetic behavior of native channels.
Isoform-Specific Modulation of Miniature
Synaptic Currents
To test directly whether the isoform-specificmodulation of
AMPA receptor gating we characterized for recombinant
channels applies to native receptors, we took advantage
of previous work showing that overexpression of stargazin
in cultured cerebellar granule cells from stargazer mice
could restore AMPA receptor-mediated synaptic re-
sponses (Chen et al., 2000; Tomita et al., 2003).
Figure 7 shows examples of AMPA receptor mEPSCs
recorded from cerebellar granule cell neurons maintained
in culture for 7–11 days. The mEPSCs in Figure 7A were
recorded from a neuron from wild-type mice. The mean
amplitude of the mEPSCs in this and five other cells was
25 ± 3 pA, and the frequency of mEPSCs was typically
about 0.2 Hz. In contrast, we failed to detect mEPSCs in
granule cells from homozygous stargazer littermates (n =
7), although the resolution of the recordings was sufficient
to detect currents of 5 pA routinely (Figure 7B). Transfec-
tion of granule cells from stargazermice with either starga-
zin or g-4 rescued synaptic transmission (Figures 7C and
7D). On average, the amplitude and frequency of mEPSCsn 55, 890–904, September 20, 2007 ª2007 Elsevier Inc. 897
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Modulate the Decay of Synaptic Currents
(A–D) Whole-cell recordings from cerebellar
granule cells. AMPA receptor-mediated
mEPSCs were routinely recorded in granule
cells from wild-type mice (A), but were never
observed in granule cells from homozygous
stargazer littermates (stg/stg, [B]). The acute
expression of either stargazin (C) or g-4 (D) res-
cued synaptic transmission in neurons from
stg/stg mice. The decay of mEPSCs in star-
gazer granule cells transfected with stargazin
was similar to the currents seen in wild-type
cells, whereas the decays of synaptic currents
in granule cells from stargazer mice that were
transfected with g-4 were consistently slower.
In each panel, six 200 ms segments of data
are superposed, and the examples do not re-
flect the observed frequency of minis (see text).
(E) Mean mEPSCs were obtained by averaging
10 to 15 synaptic currents and the decays of
the resultant currents fitted with biexponential
functions. The currents were scaled to their
peak amplitudes and the fits to the decays
are superposed on each trace.
(F) Mean (+SEM) values for the weighted time
constants obtained from fits to the decay of av-
erage mEPSCs from wild-type granule cells
(black) or granule cells from stg/stgmice. Cells
from the stargazer mice were transfected with the cDNAs encoding stargazin (red) or g-4 (green). The mean values for wild-type neurons or stg/stg
neurons transfected with STG were not significantly different from each other but were significantly smaller than the corresponding value for stg/stg
neurons transfected with g-4 (p < 0.01, one-way ANOVA).in cells transfectedwith STG and cells fromwild-typemice
were similar, whereas the amplitude and frequency of
mEPSCs in stargazer cells that were transfected with g-4
were about 50% of wild-type values. Synaptic currents
were not observed in cells transfected with eGFP alone
(n = 6).
It was clear from inspection of the results that the
mEPSCs in g-4-transfected cells were slower than those
recorded from wild-type neurons or neurons transfected
with stargazin. To quantify these differences, we first ana-
lyzed the decay of all mEPSCs using a semiautomated al-
gorithm that measures the time constant of decay by find-
ing the time at which the currents have decayed to 36.8%
of their peak amplitude (see Experimental Procedures). In
total, we analyzed 301 mEPSCs from wild-type cells and
120 and 186 mEPSCs from stargazer neurons transfected
with stargazin or g-4, respectively. ThemEPSC decays for
wild-type and stargazin-transfected cells were similar,
whereas mEPSC decays were significantly slower in cells
transfectedwithg-4 than in cells transfectedwith stargazin
(p < 0.05). To obtain a better estimate of the effect of the
two TARPs on the mEPSC time course, we averaged
10–15 mEPSCs from each cell and fitted the decays of
the mean currents with biexponential functions. Examples
of the results are shown in Figure 7E, and the mean
weighted decay time constants for each group are plotted
inFigure 7F. The value from stargazercells transfectedwith
g-4 was 2-fold greater than the values from wild-type
neurons or stargazer neurons transfected with stargazin898 Neuron 55, 890–904, September 20, 2007 ª2007 Elsevier(p < 0.01, one-way ANOVA). The size of the difference for
synaptic channels containing STG or g-4 is virtually identi-
cal to the difference seen with these TARPs for the deacti-
vation of GluR1 channels in tsA201 cells (Figure 3).
TARPs Alter the Frequency-Response
Characteristics of AMPA Receptors
At central synapses, glutamate is released repetitively in
response to presynaptic firing. Having shown that the
effects of the different TARP isoforms on the gating prop-
erties of recombinant channels accurately reflect their dis-
tinctmodulation of the properties of synaptic channels, we
next sought to determine whether TARP modulation of
AMPA receptor kinetics is likely to modulate the response
of neurons to repetitive presynaptic stimuli. In situ, these
responses are influenced by both presynaptic and post-
synaptic mechanisms. To isolate the effect of TARPs on
receptor properties from possible differences in other
synaptic properties, we therefore mimicked such stimuli
by applying brief pulses of glutamate at frequencies of
10–400 Hz to patches from tsA201 cells transfected with
GluR1 alone or from cells cotransfected with GluR1 and
stargazin or g-8 (Figure 8).
At high frequencies and a near-saturating concentration
of glutamate, the peak currents declined rapidly in
patches from cells transfected with GluR1 alone. An ex-
ample of the results obtained when three consecutive
2 ms applications of 10 mM glutamate were made at
5 ms intervals (200 Hz) is shown in the top left panel ofInc.
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TARP Isoforms and AMPA Receptor GatingFigure 8. TARP Modulation of the Response of AMPA Receptors to Repeated Applications of Glutamate
(A) Inward currents evoked by three consecutive 2 ms pulses (bars) of 10 mM or 500 mM glutamate (top and bottom rows, respectively) applied at
a frequency of 200 Hz. The currents were recorded in patches from cells transfected with GluR1 alone (left) or cotransfected with GluR1 and stargazin
or g-8 (middle and left columns, respectively). For GluR1 and GluR1 + stargazin, the records with 10 mM and 500 mM glutamate are from the same
patches. In each panel, the decay of the currents at the end of the pulses is rapid and almost reaches baseline levels with GluR1 alone. The amplitude
of subsequent responses is reduced, however, and for GluR1 and GluR1 + g-8 the envelope of the peak currents closely follows the time course with
which the currents decay during a sustained application (dotted lines in the top row show themean desensitization decays for each channel type). For
GluR1 + stargazin, the second and third peak currents are reduced less than predicted by the rate of desensitization.
(B) Mean results obtained for each channel type with 10 mM (top) or 500 mM (bottom) glutamate at stimulation frequencies of 200 and 100 Hz (left and
right panels, respectively). The amplitudes of the peak currents evoked by the second and third applicationswere divided by the amplitude of the peak
current evoked by the first application of each trial. Each data set represents results from three to six patches (bars indicate SEM).
(C) Inward currents evoked by 2 ms applications of 10mM glutamate (bars above currents) made at a frequency of 10 Hz. Responses to the first three
of nine consecutive applications are shown in patches taken from cells transfected with GluR1 alone (top) or cells cotransfected with GluR1 and star-
gazin or g-8 (middle and bottom, respectively).
(D) Mean results obtained at 10 Hz with the protocol illustrated in panel (C). The data are from three or four patches (bars indicate SEM). Curves are
single-exponential fits to the results.Figure 8A. Although the brief applications were not long
enough to reveal significant desensitization during the ap-
plications, the amplitude of the peak currents evoked by
subsequent applications was predicted well by the time
course of the current decay during sustained applicationsNeur(dotted curve). This result is consistent with previous work
indicating that desensitization occurs largely from closed
states (Raman and Trussell, 1995). Cotransfection with
either stargazin or g-8 blunted the decline in the response
to subsequent applications of glutamate (Figure 8A, topon 55, 890–904, September 20, 2007 ª2007 Elsevier Inc. 899
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less than g-8 (Table 1), the relative size of the peak cur-
rents evoked by the second and third applications of
10 mM glutamate was similar or larger with stargazin at
frequencies of 100 Hz and above (Figures 8A and 8B).
To determine whether the results depended on peak
open probability, we compared the results with 10 mM
glutamate to the corresponding results obtained with
500 mM glutamate. With GluR1 alone, applications of
500 mM glutamate gave peak currents in response to the
first applications that were about 40% of those evoked
by 10 mM glutamate in the same patches (39% ± 10%,
n = 4).While the amplitude of the second and third currents
was reduced substantially, the reductions were less than
with 10 mM glutamate (Figures 8A and 8B), presumably
because a larger proportion of the channels are
spared from desensitization (during a brief application)
when fractional occupancyof the receptorpopulation is low.
Aswas the casewith 10mMglutamate, coexpression of
either stargazin or g-8 significantly reduced the decline in
currents evoked by the second and third applications of
500 mM glutamate (Figures 8A and 8B). Both stargazin
and g-8 significantly increased the peak currents evoked
by the second and third applications, and the effects of
the two TARPs did not differ significantly from each other.
The smaller relative effects of stargazin and g-8 at subsa-
turating glutamate probably reflect an effect of TARP co-
expression on glutamate potency. Compared with GluR1
alone, the ratios of the peak currents evoked by 500 mM
and 10 mM glutamate were larger with stargazin and
g-8 (70% ± 7% and 61% ± 1%, n = 3 and 4 patches,
respectively), results consistent with previous studies
showing that stargazin coexpression results in 2- to
4-fold increases in agonist potency, as assessed by
comparisons of concentration-response curves for
steady-state currents (Priel et al., 2005; Turetsky et al.,
2005).
Coexpression of either TARP also modulated the
response of GluR1 receptors to glutamate applications
repeated at lower frequencies. Examples of the results
obtained when 2 ms applications of 10 mM glutamate
were made at 100 ms intervals (10 Hz) are shown in
Figure 8C. As can be seen, both TARPs increased the
size of the currents evoked by subsequent applications.
The rate at which the peak currents declined was similar
for all three types of channel (Figure 8D), but the peak cur-
rents evoked by the second and third pulse were signifi-
cantly greater with stargazin and g-8, and the steady-state
peak currents were significantly different for all three
groups (assessed by comparing the mean peak ampli-
tudes for the last six applications). Unlike the effects of
stargazin and g-8 at short application intervals (Figure 8B),
at low stimulation frequencies coexpression of g-8 blun-
ted the decline in the currents more than stargazin
(Figure 8D). Thus, not only does TARP coexpression mod-
ulate the response of AMPA receptors to repeated activa-
tion, but the frequency dependence of this modulation
varies for different TARP isoforms.900 Neuron 55, 890–904, September 20, 2007 ª2007 Elsevier IDISCUSSION
Stargazin was the first auxiliary protein shown to have ef-
fects on AMPA receptor gating properties (Priel et al.,
2005; Tomita et al., 2005; Turetsky et al., 2005; Yamazaki
et al., 2004). Although it is generally agreed that stargazin
and other TARP isoforms slow the rate at which AMPA re-
ceptors desensitize during sustained applications, as yet
there is no consensus on themolecularmechanism under-
lying this effect. Because stargazin also slows deactiva-
tion (the decay of currents evoked by brief pulses of gluta-
mate) and did not alter the mean duration of channel
openings, we concluded that the primary effect of starga-
zin was to increase the rate constant for channel opening
(Tomita et al., 2005). Other groups concluded that starga-
zin directly alters desensitization (Kott et al., 2007; Priel
et al., 2005; Turetsky et al., 2005). Our findings that all
four TARP isoforms investigated here slow both deactiva-
tion and desensitization to similar extents, as well as the
similar slowing of deactivation seen with stargazin in the
presence and absence of CTZ (Tomita et al., 2006; Zhang
et al., 2006), argue strongly that TARP-mediated slowing
of desensitization is a secondary consequence of TARP
effects on activation gating.
Several previous studies have focused mainly on the
properties of steady-state currents evoked by kainate
and glutamate, and in some of these studies the currents
analyzed have either been very small (Kott et al., 2007) or
the solution exchange times were too slow to measure the
extent and rate of desensitization accurately (Korber et al.,
2007a, 2007b; Turetsky et al., 2005). Synaptic events are
by nature transient. If the mechanisms underlying TARP
modulation of gating are to be elucidated and their impact
on synaptic transmission understood, it is essential that
glutamate-evoked currents be studied under conditions
that mimic the synaptic release of glutamate. In contrast
to most previous work, the rise times of the currents
recorded in our experiments are similar to the rise times
of EPSCs, and responses to both brief and long applica-
tions of glutamate were characterized. In addition to
slowing deactivation and desensitization, we show that
TARP modulation of activation gating also results in
isoform-specific increases in peak Popen.
Unlike previous work (Turetsky et al., 2005), we do not
find significant differences in the modulation of GluR1
channel gating produced by stargazin and g-3. In our
hands, these two isoforms produced smaller effects on
the kinetics of glutamate-evoked currents through GluR1
channels, and larger increases in kainate efficacy, than
g-4 and g-8, suggesting that the four TARP isoforms com-
prise two subgroups. The data obtained for GluR4, as well
as GluR1-GluR2 heteromeric channels, support these
conclusions. Our results with stargazin/g-4 chimeras indi-
cate that the different effects of the two subgroups on the
kinetics of glutamate-evoked currents appear to result
almost entirely from differences in the Ex1 domain.
In addition to the four TARP isoforms studied here, re-
cent work shows that g-7 also modulates AMPA receptornc.
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seen with this isoform was less than with stargazin, sug-
gesting that it may belong to yet another subfamily of
this important class of auxiliary AMPA receptor subunits.
TARPs Tune the Frequency-Response Properties
of AMPA Receptors
Importantly, the quantitative differences in receptor kine-
tics seen in our experiments on recombinant channels
were maintained when stargazin and g-4 were selectively
expressed in neurons from stargazermice. The differential
slowing of the decay ofmEPSCs in these experiments was
virtually identical to the slowing of deactivation decays
seen for GluR1 channels, clearly demonstrating that the
isoform-specific modulation of gating kinetics character-
ized here is relevant to synaptic transmission in neurons.
Another interesting aspect of the effect of TARP coex-
pression on the kinetic behavior of AMPA receptors is the
impact it has on the response of the receptors to repeated
activation. The results in Figure 8 show clearly that TARP
modulation of AMPA receptor gating has significant effects
on the response of the receptors to multiple brief applica-
tions of glutamate, applications that mimic the exposure
to glutamate that synaptic receptors would experience
during trains of presynaptic action potentials. Our results
show that the magnitude of these effects depends on
both glutamate concentration and the frequency at which
the applications are made. At short application intervals,
the effect of TARPs to slow decay kinetics plays a major
role in the modulation of subsequent responses, although
with stargazin the modulation at 100 and 200 Hz stimula-
tion is larger than expected from the slower decays alone,
suggesting that other factors also contribute. The effects
we observed are substantial and would be expected to
contribute to paired-pulse facilitation, as well as vary with
release probability. At stimulation frequencies of 20 Hz
and below, the increases in the currents seen are not influ-
enced directly by the effects on decay kinetics and proba-
bly reflect aneffectof TARPcoexpressionon recovery from
desensitization (Priel et al., 2005). The different results with
stargazin and g-8 at low stimulation frequencies suggest
that TARP effects on recovery are also isoform specific.
The shape of EPSCs in CNS neurons and the ability of
excitatory synapses to follow high-frequency presynaptic
firing are controlled by several factors—structural organi-
zation of the synapse, the rate of glutamate clearance,
a variety of presynaptic factors, and the number, location,
and subunit composition of postsynaptic receptors (Bel-
lingham et al., 1998; Diamond and Jahr, 1997; Silver
et al., 1996; Trussell et al., 1993). Clearly, local circuits,
as well as the repertoire of voltage-gated channels ex-
pressed in both presynaptic and postsynaptic neurons,
also play major roles. In addition, the decay of EPSCs is
strongly influenced by the rates at which AMPA receptors
deactivate and desensitize, and desensitization can be
a major factor controlling the response of synapses to
high-frequency firing (Conti and Weinberg, 1999; Jonas
and Spruston, 1994; Otis et al., 1996; Trussell et al., 1993).NeuAs for individual AMPA receptor subunits (Monyer et al.,
1991), different TARP isoforms display different expres-
sion patterns in brain (Fukaya et al., 2005; Tomita et al.,
2003). For example, stargazin is expressed in cerebellum,
cerebral cortex, and hippocampus, whereas g-3 is abun-
dant in cerebral cortex and amygdala, g-4 is expressed at
high levels in striatum and thalamus, and g-8 is abundant
in hippocampus. This differential expression, together
with the results reported here, suggests that the GluR/
TARP composition of AMPA receptors contributes to syn-
apse-specific differences in EPSC kinetics (Conti and
Weinberg, 1999; Jonas and Spruston, 1994). As one ex-
ample, the expression of stargazin at mossy fiber-granule
cell synapses in cerebellum, and the high expression of
g-8 in hippocampus, may contribute to the slower decay
of EPSCs in hippocampus compared with mossy fiber-
granule cell EPSCs, as well as the different kinetics of glu-
tamate-activated currents in patches from hippocampal
and cerebellar neurons (Colquhoun et al., 1992; Jonas
et al., 1993; Livsey et al., 1993; Silver et al., 1996; Traynelis
et al., 1993; Wall et al., 2002). Our findings that stargazin
reconstitutes wild-type mEPSC kinetics in stargazer
granule cells, whereas mEPSC decays are substantially
slower in stargazer neurons expressing g-4, support this
possibility. In total, our results suggest that isoform-spe-
cific differences in TARP modulation of AMPA receptor
properties are an important mechanism for tuning the
frequency-response characteristics of mammalian central
synapses.
TARP Coassembly Promotes a Slow Gating Mode
As in our previous work on stargazin (Tomita et al., 2005;
Zhang et al., 2006), each TARP produced significant in-
creases in the amplitude of the slow component of decay,
evident either at the end of short glutamate applications
(deactivation) or during sustained applications of saturat-
ing glutamate (desensitization). Indeed, while the different
isoforms displayed significant differences in the extent to
which they slow the time constants of decay, and this also
varied for different GluR isoforms, all the TARP/GluR com-
binations tested resulted in similar increases in the ampli-
tude of the slow component. Thus, TARP coexpression
not only slows decay kinetics but it changes the character
of the decay by promoting a different mode of gating. Pos-
sible mechanisms for this effect of TARPs are discussed in
the Supplemental Data.
The TARP-associated increases in the slow gating com-
ponent contribute substantially to the large increases in to-
tal charge transfer seen for deactivation decays upon
TARPcoexpression,whichare4-fold forg-4 andg-8 (Table
2), and there is evidence that stargazin also markedly in-
creases charge transfer duringglutamate-evoked synaptic
currents (Tomita et al., 2005). Because most native recep-
tors show appreciable permeability to calcium, the in-
creases in charge transfer associated with the inclusion
ofTARPs inAMPAreceptor assemblieswouldbeexpected
to increase significantly the calcium influx during single
EPSCs, likely boosting calcium-dependent signaling.ron 55, 890–904, September 20, 2007 ª2007 Elsevier Inc. 901
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Studies on Recombinant Channels
tsA201 cells were maintained and transfected as previously described
(Robert and Howe, 2003). All GluR plasmids used were flip splice var-
iants. Both Q and R variants of GluR2 were used as indicated. Individ-
ual GluR and TARP clones were cotransfected at ratios of 1:2 to 1:5. In
the GluR1-GluR2 coexpression experiments, the flip version of GluR2-
R was employed, and equal amounts of the two GluR plasmids were
transfected. Chimeras in which the first extracellular domain (from
D31 to S105 for stargazin and D31 to S108 for g-4) was exchanged be-
tween stargazin and g-4 (STG-Ex1-g-4 and g-4-Ex1-STG) were con-
structed with PCR. Putative chimeric constructs were selected by di-
agnostic restriction digests and verified by sequencing.
Recordings from outside-out patches were performed 1–3 days
posttransfection at room temperature with an EPC-9 amplifier
(HEKA) as described previously (Robert et al., 2001). The holding po-
tential was between 80 and 120 mV. The external solution was (in
mM) 150 NaCl, 3 KCl, 2 CaCl2, 1 MgCl2, 5 glucose, and 10 HEPES
(pH 7.4). Patch pipettes (open tip resistance 3–5 MU) were filled with
a solution containing (in mM) 120 KF, 33 KOH, 2 MgCl2, 1 CaCl2, 11
EGTA, and 10 HEPES (pH 7.4). The size of the peak ensemble currents
was typically 200–500 pA, and voltage errors due to uncompensated
series resistance were estimated to be less than 5%.
Glutamate, kainate, and cyclothiazide were added to the external
solution and were applied with theta glass pipettes mounted on a
piezoelectric bimorph. The 10%–90% rise times of agonist-evoked
currents were typically 0.4–0.6 ms, and the rate of solution exchange
estimated from open-tip potentials was 100–200 ms. The bath was
superfused constantly with normal external solution flowing at a rate
of 1 ml/min. Oocyte experiments were conducted as described
previously (Tomita et al., 2005).
Synaptic Currents in Transfected Cerebellar Granule Cells
Stargazer mice were obtained from Jackson Laboratory and main-
tained at the Yale animal facility under the guidelines of the Institutional
Animal Care and Use Committee. Heterozygousmale and female mice
were mated to obtain wild-type and homozygous stargazermice. Cer-
ebellar granule cell cultures were prepared from postnatal day 7 (P7)
wild-type and homozygous stargazer mice as described (Losi et al.,
2003). Briefly, cerebella were removed and treated with trypsin, and
primary cultures were plated on poly-lysine-coated glass coverslips
at a density of 1.03 106 cells per well and maintained in basal Eagle’s
mediawith 10% fetal bovine serum. At DIV4, themediumwas replaced
with MEMmedium containing glucose (5 mg/ml), insulin-transferin-so-
dium selenate (Sigma), gentamycin (10 mg/ml), and cytosine arabino-
furanoside hydrochloride (4 mM). Each coverslip was transfected at
DIV5 with calcium phosphate, 2 mg of cDNA encoding STG or g-4,
and 0.6 mg of cDNA encoding eGFP. Patch-clamp recordings from cer-
ebellar granule cells (DIV6–11) were made in external solution contain-
ing (in mM) 119 NaCl, 2.5 KCl, 2.5 CaCl2, 1.3 MgSO4, 2.7 MgCl2, 1
NaHPO4, 26.2 NaHCO3, and 11 glucose. Sucrose (50 mM) was added
to facilitate transmitter release, and the pH was adjusted to 7.4. Patch
pipettes were filled with recording solution (pH 7.2) that contained (in
mM) 145 K-gluconate, 5 HEPES, 5 Mg-ATP, 0.2 Na-GTP, and 10
EGTA. All recordings were performed at room temperature. To isolate
and record AMPA receptor-mediated mEPSCs, tetrodotoxin (1 mM),
AP-5 (50 mM), and picrotoxin (0.1 mM) were added to the external so-
lution. mEPSCs were recorded from cerebellar granule cells in whole-
cell configuration at a holding potential of70mV. The current was an-
alog low-pass filtered at 3 kHz and digitally sampled at 25 kHz.
Analysis and Statistics
Agonist-evoked currents recorded in outside-out patches were analog
low-pass filtered at 3 kHz and were written directly to the hard-drive of
the computer at sampling rates of 20–30 kHz. The digital records were
analyzed using Igor software (Wavemetrics, Lake Oswego, OR). Typi-902 Neuron 55, 890–904, September 20, 2007 ª2007 Elsevier Ically, currents evoked by six to ten trials were averaged, and exponen-
tial functions (plus a steady-state plateau current) were fitted to the
decays of the mean currents (desensitization and deactivation). The
currents were very small in the GluR1-GluR2 coexpression studies
and a larger number of records were averaged (20 to 50). In these latter
experiments, peak current-voltage curves for individual records were
obtained by making 50 ms applications of 10 mM glutamate during
200 ms voltage jumps from 80 mV to +80 mV (in 10 mV steps). For
each patch, peak current amplitudes were normalized to the value ob-
tained at 80 mV, and the mean results obtained for each GluR-TARP
combination tested were fitted with third-order polynomial functions.
The software package Minianalysis (Synaptosoft, Decatur, GA) was
used to measure the decay time, amplitude, and frequency of
mEPSCs. The detection threshold was set to 7 pA, and all events
were inspected to ensure they were mEPSCs. From each cell ana-
lyzed, 10 to 15 representative mEPSCs were scaled to the same
peak amplitude, averaged, and the decays of the mean currents
were fitted with biexponential functions.
The number of exponential components required to fit the decay of
glutamate-evoked or synaptic currents was determined as described
in detail before (Robert et al., 2001; Zhang et al., 2006). In all cases,
the inclusion of a second exponential component improved the fits
to the decays significantly. For statistical comparisons of mean values
for multiple groups, we first performed F-ratio tests to test for homoge-
neity of variance. When the variance was homogeneous across all
groups, comparisons were made with a one-way ANOVA. In all other
cases, pairwise comparisons where made with a two-tailed Student’s
t test (assuming unequal variance). Differences were considered
significant for p < 0.05.
Supplemental Data
The Supplemental Data for this article can be found online at http://
www.neuron.org/cgi/content/full/55/6/890/DC1/.
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